EXACT Therapeutics Feed

	Est. tid*
2025-09-25	-	Kvartalsrapport 2025-Q2
2025-06-16	-	X-dag ordinarie utdelning EXTX 0.00 NOK
2025-06-13	-	Årsstämma
2025-04-09	-	Bokslutskommuniké 2024
2024-12-17	-	Extra Bolagsstämma 2024
2024-09-30	-	Kvartalsrapport 2024-Q2
2024-06-28	-	Årsstämma
2024-06-10	-	X-dag ordinarie utdelning EXTX 0.00 NOK
2024-04-18	-	Bokslutskommuniké 2023
2023-09-28	-	Kvartalsrapport 2023-Q2
2023-06-12	-	X-dag ordinarie utdelning EXTX 0.00 NOK
2023-06-09	-	Årsstämma
2023-04-21	-	Bokslutskommuniké 2022
2022-09-22	-	Kvartalsrapport 2022-Q2
2022-06-09	-	X-dag ordinarie utdelning EXTX 0.00 NOK
2022-06-08	-	Årsstämma
2022-04-27	-	Bokslutskommuniké 2021
2021-08-25	-	Kvartalsrapport 2021-Q2
2021-06-01	-	Årsstämma
2021-05-14	-	X-dag ordinarie utdelning EXTX 0.00 NOK
2021-04-29	-	Bokslutskommuniké 2020
2020-07-27	-	Split EXTX 1:250
2020-07-24	-	Extra Bolagsstämma 2020

Land	Norge
Lista	Euronext Growth Oslo
Sektor	Hälsovård
Industri	Bioteknik

2025-09-25 08:00:00 EXTX: EXACT Therapeutics first half 2025 interim results 2,00 NOK | +5,26% | 0,20 MNOK

2025-09-18 08:00:00 EXTX: EXACT Therapeutics' Phase 2 trial to be presented at the 2025 AACR Special Conference 2,20 NOK | -1,79% | 0,00 MNOK

2025-09-09 08:00:00 EXTX: EXACT Therapeutic's Acoustic Cluster Therapy to be presented at the Ninth International Cancer lmmunotherapy Conference 2,24 NOK | 0,00% | 0,05 MNOK

2025-08-12 08:30:00 EXTX: EXACT Therapeutics to Present at the European Society for Medical Oncology (ESMO) Congress 2025

2025-08-11 11:08:28 EXTX: Financial calendar 2,76 NOK | +2,99% | 0,02 MNOK

2025-07-08 08:30:00 EXTX: EXACT Therapeutics announces grant of core patent in the U.S. 2,80 NOK | -0,71% | 0,02 MNOK

2025-06-24 08:00:00 EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer 2,70 NOK | -3,57% | 0,19 MNOK

2025-06-24 08:00:00 EXTX: EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer 2,70 NOK | -3,57% | 0,19 MNOK

2025-06-13 12:09:49 EXACT Therapeutics AS: Primary insider notification 2,96 NOK | +13,85% | 0,01 MNOK

2025-06-13 12:05:27 EXTX: EXACT Therapeutics minutes from Annual General Meeting June 13, 2025 2,96 NOK | +13,85% | 0,01 MNOK

2025-06-04 09:20:37 EXACT Therapeutics AS - Information regarding voting at the Annual General Meeting 2025 2,70 NOK | +4,65% | 0,10 MNOK

2025-05-28 14:53:38 EXACT Therapeutics AS - Notice of Annual General Meeting 2025 2,98 NOK | +7,19% | 0,00 MNOK

2025-05-20 08:30:00 EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer 2,94 NOK | -2,00% | 0,61 MNOK

2025-05-20 08:30:00 EXTX: EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer 2,94 NOK | -2,00% | 0,61 MNOK

2025-05-14 08:35:45 EXTX: EXACT Therapeutics announces grant of key patent covering non-invasive delivery of pharmaceuticals to the brain 3,10 NOK | +13,97% | 0,01 MNOK

2025-05-07 10:47:40 EXTX: EXACT Therapeutics announces grant of key patent in Japan 2,80 NOK | -6,67% | 0,25 MNOK

2025-04-09 21:17:44 EXACT Therapeutics - 2024 Annual Report

2025-01-28 08:00:00 EXTX: EXACT Therapeutics and Cordance Medical Announce Early Encouraging Data in Brain Cancer Mice Model 3,50 NOK | +8,70% | 0,28 MNOK

2025-01-07 11:58:03 EXTX: Financial calendar 3,40 NOK | -1,73% | 0,25 MNOK

2024-12-24 12:52:50 EXACT Therapeutics AS: Share capital increase registered

2024-12-19 15:37:40 EXACT Therapeutics AS: Primary insider notification 3,58 NOK | -7,25% | 0,21 MNOK

2024-12-19 09:01:22 EXTX: EXACT Therapeutics Expands its Board of Directors following the EGM 3,58 NOK | -7,25% | 0,21 MNOK

2024-12-18 11:36:22 EXACT Therapeutics AS: Cancellation of subsequent offering 3,86 NOK | +14,88% | 0,14 MNOK

2024-12-17 12:00:00 EXACT Therapeutics AS: Minutes from the extraordinary general meeting 3,36 NOK | -4,55% | 0,19 MNOK

2024-12-16 08:00:00 EXTX: EXACT Therapeutics Announces FDA Clearance of IND for ENACT, a Phase 2 Trial in Pancreatic Cancer 3,52 NOK | -2,22% | 0,40 MNOK

2024-12-11 18:47:10 EXACT Therapeutics AS: Primary insider notification 3,80 NOK | +0,53% | 0,33 MNOK

2024-12-11 11:44:11 EXACT Therapeutics AS: Share capital increase registered 3,78 NOK | 0,00% | 0,55 MNOK

2024-12-03 14:23:34 EXACT Therapeutics AS: Notice of extraordinary general meeting 4,00 NOK | -33,33% | 41,1 MNOK

2024-12-03 08:21:55 EXTX: EXACT Therapeutics to host virtual company presentation on December 4, 2024 following the announcement of completion of private placement 4,00 NOK | -33,33% | 41,1 MNOK

2024-12-03 00:12:26 EXACT Therapeutics AS: Key information regarding potential subsequent offering

2024-12-03 00:08:39 EXACT Therapeutics AS: Private placement successfully placed

2024-12-02 16:38:36 EXTX: EXACT Therapeutics Receives Investment from GE HealthCare to Advance Therapeutic Ultrasound in Pancreatic Cancer using ACT® 4,00 NOK | -33,33% | 41,1 MNOK

2024-12-02 16:30:00 EXACT Therapeutics AS: Contemplated Private Placement 4,00 NOK | -33,33% | 41,1 MNOK

2024-10-08 10:04:14 EXTX: EXACT Therapeutics initiates preclinical immunotherapy collaboration with Agenus Inc. 5,75 NOK | 0,00%

2024-10-02 08:30:00 EXTX: EXACT Therapeutics to Present at the bi-annual Contrast Media Research (CMR) Symposium 2024

2024-09-30 08:00:00 EXTX: EXACT Therapeutics announces first half 2024 interim results 5,75 NOK | 0,00%

2024-09-25 09:00:23 EXTX: EXACT Therapeutics announces grant of immunotherapy patent 5,20 NOK | +4,00% | 0,02 MNOK

2024-09-18 20:30:50 EXTX: EXACT Therapeutics to Present at the Annual International Symposium on Therapeutic Ultrasound (ISTU 2024) 5,00 NOK | -3,85% | 0,01 MNOK

2024-09-13 15:18:52 EXTX: Financial calendar

2024-08-06 18:33:13 EXACT Therapeutics Company update: Full focus on Phase 2 pancreatic cancer trial 6,55 NOK | 0,00% | 0,02 MNOK

2024-06-28 11:47:40 EXTX: EXACT Therapeutics minutes from Annual General Meeting June 28, 2024 7,40 NOK | 0,00%

2024-06-14 09:00:00 EXACT Therapeutics AS - Notice of Annual General Meeting 2024 7,40 NOK | -8,64% | 0,02 MNOK

2024-05-23 09:23:49 EXTX: Financial calendar 7,10 NOK | 0,00%

2024-04-18 20:46:28 EXTX: EXACT Therapeutics Annual report 2023 7,00 NOK | 0,00% | 0,02 MNOK

2024-04-10 08:57:56 EXTX: Additional promising clinical data from EXACT Therapeutics' ongoing ACTIVATE study presented at AACR Annual Meeting 6,00 NOK | +0,84% | 0,06 MNOK

2024-03-06 21:05:25 EXTX: EXACT Therapeutics to Present at 2024 American Association for Cancer Research (AACR) Annual Meeting 9,95 NOK | 0,00%

2024-01-22 14:09:59 EXTX: Financial calendar 12,00 NOK | 0,00%

2023-12-20 11:41:02 EXACT Therapeutics AS - Share capital increase registered. Correction. 12,00 NOK | -4,00% | 0,05 MNOK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

EXACT Therapeutics

Kalender

Beskrivning

EXACT Therapeutics

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden